Allspring Global Investments’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-48,769
Closed -$3.36M 2548
2024
Q1
$3.36M Sell
48,769
-503
-1% -$33.9K 0.01% 1055
2023
Q4
$3.07M Buy
49,272
+3,182
+7% +$178K 0.01% 1066
2023
Q3
$2.59M Sell
46,090
-108,106
-70% -$6.08M ﹤0.01% 1126
2023
Q2
$7.78M Sell
154,196
-167,503
-52% -$8.91M 0.01% 857
2023
Q1
$17.6M Sell
321,699
-145,317
-31% -$8.49M 0.03% 638
2022
Q4
$29.2M Buy
467,016
+87,989
+23% +$5.84M 0.05% 467
2022
Q3
$26.7M Sell
379,027
-35,558
-9% -$2.45M 0.05% 485
2022
Q2
$23.5M Sell
414,585
-126,271
-23% -$6.92M 0.04% 533
2022
Q1
$33.9M Sell
540,856
-6,520
-1% -$351K 0.04% 506
2021
Q4
$30.7M Buy
+547,376
New +$33.4M 0.03% 571

Other funds holding AXNX

Allspring Global Investments's AXNX Position: Q2 2024 in Review

Allspring Global Investments sold out of Axonics, Inc. Common Stock (AXNX) in Q2 2024, closing a stake of 48,769 shares — an estimated $3.36M sold.

Allspring Global Investments first reported a position in AXNX in Q4 2021 and held it in 10 quarters. The position peaked at $33.9M in Q1 2022. 235 funds tracked by Wall St. Rank hold AXNX as of Q2 2024.

  • Allspring Global Investments reported no remaining Axonics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 48,769 Axonics, Inc. Common Stock shares in Q2 2024, an estimated $3.36M.
  • Allspring Global Investments first reported a position in Axonics, Inc. Common Stock in Q4 2021 and held it in 10 quarters.
  • Allspring Global Investments's Axonics, Inc. Common Stock position peaked at $33.9M in Q1 2022.
  • 235 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.